BACKGROUND/AIM: Vascular risk factors play an important role in the progression of @entity195 ( @entity195 ). Mean platelet volume ( @entity6688 ) is a determinant of platelet functionality and increased @entity6688 is associated with an increased risk of @entity32 . Here we aimed to examine whether @entity6688 could be used as a marker of @entity1504 in @entity195 and to discuss the relation between @entity6688 and other vascular risk factors. MATERIALS AND METHODS: A total of 109 outpatients with @entity195 and 81 healthy controls were included in this study. Diagnosis of @entity195 was made according to defined criteria. The Turkish version of the Mini Mental State Examination (MMSE) was used for cognitive assessment. According to the test results, @entity1 were divided into 2 subgroups, mild (MMSE >=  18) and moderate (MMSE < 18), and their @entity6688 levels were compared. RESULTS: @entity6688 levels were higher in the @entity195 group. There was no statistically significant difference between the moderate group and the mild group according to @entity6688 values. CONCLUSION: Increased @entity6688 in @entity1 with @entity195 may point to @entity1423 . @entity6688 is an indicator of increased in vivo platelet activation. Hence, platelets could be the link between vascular risk factors and @entity195 . The assessment of @entity6688 in @entity1 with @entity195 may help identify the @entity1 that could benefit from additional antiplatelet therapy.

The increase of mean platelet volume in @entity1 with XXXX .

@entity1 :: ('9606', 'Species') :: ['patients'] @entity32 :: ('MESH:D007249', 'Disease') :: ['vascular inflammation'] @entity1423 :: ('MESH:D001791', 'Disease') :: ['platelet dysfunction'] @entity1504 :: ('MESH:D002561', 'Disease') :: ['vascular damage'] @entity195 :: ('MESH:D000544', 'Disease') :: ['AD', 'Alzheimer disease'] @entity6688 :: ('10244', 'Species') :: ['MPV']
@entity195 :: (MESH:D000544,Disease) :: ['Alzheimer disease']
